APA (7th ed.) Citation

V, L., S, L., W, P., A, J., S, N., S, M., . . . P, P. (2025). Immune responses to a heterologous booster with mRNA based COVID-19 vaccine after priming with an inactivated Newcastle disease virus recombinant vaccine expressing the SARS-CoV-2 spike protein (NDV-HXP-S). Vaccine, 62, 127601. https://doi.org/10.1016/j.vaccine.2025.127601

Chicago Style (17th ed.) Citation

V, Luvira, et al. "Immune Responses to a Heterologous Booster with MRNA Based COVID-19 Vaccine After Priming with an Inactivated Newcastle Disease Virus Recombinant Vaccine Expressing the SARS-CoV-2 Spike Protein (NDV-HXP-S)." Vaccine 62 (2025): 127601. https://doi.org/10.1016/j.vaccine.2025.127601.

MLA (9th ed.) Citation

V, Luvira, et al. "Immune Responses to a Heterologous Booster with MRNA Based COVID-19 Vaccine After Priming with an Inactivated Newcastle Disease Virus Recombinant Vaccine Expressing the SARS-CoV-2 Spike Protein (NDV-HXP-S)." Vaccine, vol. 62, 2025, p. 127601, https://doi.org/10.1016/j.vaccine.2025.127601.